Venetoclax (Venclyxto▼): updated recommendations on tumour lysis syndrome (TLS)

2021-12-10T11:01:39+00:00

Fatal cases of tumour lysis syndrome (TLS) have been reported, some occurring in patients with chronic lymphocytic leukaemia receiving the lowest venetoclax dose used in the dose-titration schedule. For all patients, it is i…